AGREEMENT
EXHIBIT A
AGREEMENT
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Theseus Pharmaceuticals, Inc.
Date: February 13, 2024 | XXXXXXX LIFE SCIENCES PUBLIC FUND, L.P. | |||||
By: FHMLSP, L.P., its General Partner | ||||||
By: FHMLSP, L.L.C., its General Partner | ||||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: February 13, 2024 | FHMLSP, L.P. | |||||
By: FHMLSP, L.L.C., its General Partner | ||||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: February 13, 2024 | FHMLSP, L.L.C. | |||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: February 13, 2024 | XXXXXXX LIFE SCIENCES PUBLIC OVERAGE FUND, L.P. | |||||
By: FHMLSP Overage, L.P., its General Partner | ||||||
By: FHMLSP Overage, L.L.C., its General Partner | ||||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: February 13, 2024 | FHMLSP OVERAGE, L.P. | |||||
By FHMLSP Overage, L.L.C., its General Partner | ||||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: February 13, 2024 | FHMLSP OVERAGE, L.L.C. | |||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: February 13, 2024 | XXXXXXX LIFE SCIENCES XI, L.P. | |||||
By: FHMLS XI, L.P., its General Partner | ||||||
By: FHMLS XI, L.L.C., its General Partner | ||||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer |
Date: February 13, 2024 | FHMLS XI, L.P. | |||||
By: FHMLS XI, L.L.C., its General Partner | ||||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: February 13, 2024 | FHMLS XI, L.L.C. | |||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: February 13, 2024 | By: | * | ||||
Xxxxx X. Xxxxxx | ||||||
Date: February 13, 2024 | By: | * | ||||
Xxxxxxx X. Xxxxx | ||||||
Date: February 13, 2024 | By: | ** | ||||
Xxxxxx Xxx | ||||||
Date: February 13, 2024 | By: | ** | ||||
Xxxxx Xxxxx | ||||||
Date: February 13, 2024 | By: | *** | ||||
Xxxxxx Xxxxx | ||||||
Date: February 13, 2024 | By: | /s/ Xxxxx X. Xxxxxx | ||||
Xxxxx X. Xxxxxx, as Attorney-in-Fact |
* | This Agreement was executed by Xxxxx X. Xxxxxx on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on March 29, 2016. |
** | This Agreement was executed by Xxxxx X. Xxxxxx on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on August 16, 2021. |
*** | This Agreement was executed by Xxxxx X. Xxxxxx on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on April 18, 2022. |